Building Manufacturing Capacity

Shortages in quality-assured medicines impede efforts to reduce the prevalence of tuberculosis, malaria, and HIV/AIDS, and undermine progress in maternal and child health. Investments that build capacity of local manufacturers to produce medicines according to international quality standards and help bring low-cost, essential medicines to markets and patients faster are urgently needed.

Our Approach

USP collaborates with USAID, WHO, and other partners to increase the supply of priority, quality-assured, essential medicines. Our technical assistance helps companies build stronger quality-assurance systems and satisfy regulatory requirements for marketing authorization and procurement.

Areas of Technical Support & Training

  • Active pharmaceutical ingredient and product development
  • Technology transfer
  • Process scale up
  • Dossier compilation
  • Good Manufacturing Practices
  • WHO prequalification and Stringent Regulatory Authority (SRA) approval
  • Provision of public standards
female pharmacist